Ameriprise’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-93,139
| Closed | -$513K | – | 4020 |
|
|
2022
Q1 | $513K | Buy |
93,139
+10,628
| +13% | +$58.5K | ﹤0.01% | 3478 |
|
|
2021
Q4 | $798K | Buy |
82,511
+22,453
| +37% | +$217K | ﹤0.01% | 3351 |
|
|
2021
Q3 | $1.07M | Buy |
60,058
+6,797
| +13% | +$122K | ﹤0.01% | 3139 |
|
|
2021
Q2 | $1.3M | Buy |
53,261
+4,838
| +10% | +$118K | ﹤0.01% | 3109 |
|
|
2021
Q1 | $1.28M | Sell |
48,423
-63,381
| -57% | -$1.68M | ﹤0.01% | 3036 |
|
|
2020
Q4 | $848K | Sell |
111,804
-23,776
| -18% | -$180K | ﹤0.01% | 3157 |
|
|
2020
Q3 | $680K | Sell |
135,580
-85
| -0.1% | -$426 | ﹤0.01% | 3131 |
|
|
2020
Q2 | $812K | Buy |
135,665
+19,711
| +17% | +$118K | ﹤0.01% | 3005 |
|
|
2020
Q1 | $517K | Buy |
115,954
+1,583
| +1% | +$7.06K | ﹤0.01% | 3110 |
|
|
2019
Q4 | $1.09M | Buy |
114,371
+28,841
| +34% | +$274K | ﹤0.01% | 3020 |
|
|
2019
Q3 | $672K | Sell |
85,530
-48,681
| -36% | -$382K | ﹤0.01% | 3185 |
|
|
2019
Q2 | $2.11M | Buy |
134,211
+34,080
| +34% | +$536K | ﹤0.01% | 2717 |
|
|
2019
Q1 | $1.81M | Buy |
100,131
+83,031
| +486% | +$1.5M | ﹤0.01% | 2782 |
|
|
2018
Q4 | $275K | Buy |
+17,100
| New | +$275K | ﹤0.01% | 3368 |
|